Healthy volunteers needed to test two new drug formulations in Early-Stage trial
NCT ID NCT07364851
First seen Jan 27, 2026 · Last updated Jun 10, 2026 · Updated 26 times
Summary
This early-stage study tests two experimental drugs (DW4421-T1 and DW4421S-T1) in 38 healthy adults aged 19 to 50. The goal is to check how safe they are and how the body processes them. Participants will receive a single dose of each drug in a random order and be monitored closely. No treatment benefit is expected, as this is purely a safety and drug-level study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chungbuk National University Hospital
Cheongju-si, South Korea
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.